Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L E Morris
Preemptive DLI Without Withdrawal of Immunosuppression to Promote Complete Donor T-Cell Chimerism Results in Favorable Outcomes for High-Risk Older Recipients of Alemtuzumab-Containing Reduced-Intensity Unrelated Donor Allogeneic Transplant: A Prospective Phase II Trial
Bone Marrow Transplantation
Transplantation
Hematology
Outpatient Myeloablative Allo-Sct: A Comprehensive Approach Yields Decreased Hospital Utilization and Low TRM
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Reduced Intensity Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Patients With Early Initiation of DLI for Mixed Donor Chimerism Were More Likely to Have Improvement in Donor Chimerism
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Randomized Phase II Trial Comparing Two Dose Levels of Thymoglobulin in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Donor Race and Outcomes in Kidney Transplant Recipients
Clinical Transplantation
Transplantation
A Randomised Controlled Trial of Total Immunosuppression Withdrawal in Stable Liver Transplant Recipients
Gut
Gastroenterology
Unrelated Donor Transplantation in Children With Thalassemia Using Reduced Intensity Conditioning - The URTH Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Durable Graft-Versus-Leukaemia Effects Without Donor Lymphocyte Infusions - Results of a Phase II Study of Sequential T-Replete Allogeneic Transplantation for High-Risk Acute Myeloid Leukaemia and Myelodysplasia
British Journal of Haematology
Hematology
Rapid Induction of Complete Donor Chimerism by the Use of a Reduced-Intensity Conditioning Regimen Composed of Fludarabine and Melphalan in Allogeneic Stem Cell Transplantation for Metastatic Solid Tumors
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
